Trexquant Investment LP Alnylam Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 90,743 shares of ALNY stock, worth $25.3 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

90,743

Previous 37,863 139.66%

Holding current value

$25.3 Million

Previous $9.2 Million 171.32%

% of portfolio

0.33%

Previous 0.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$233.81 - $287.01 $12.4 Million - $15.2 Million	52,880 Added 139.66%	90,743 $25 Million
Q2 2024 Aug 13, 2024	SELL	$143.31 - $247.0 $8.47 Million - $14.6 Million	-59,112 Reduced 60.96%	37,863 $9.2 Million
Q1 2024 May 14, 2024	BUY	$146.51 - $198.2 $6.68 Million - $9.03 Million	45,578 Added 88.68%	96,975 $14.5 Million
Q4 2023 Feb 09, 2024	BUY	$151.41 - $196.57 $6.11 Million - $7.94 Million	40,376 Added 366.36%	51,397 $9.84 Million
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $1.88 Million - $2.33 Million	11,021 New	11,021 $1.95 Million
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $104,082 - $135,374	561 Added 1.3%	43,673 $10.4 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $5.97 Million - $10 Million	43,112 New	43,112 $8.63 Million
Q2 2022 Aug 11, 2022	SELL	$120.42 - $169.29 $2.59 Million - $3.64 Million	-21,496 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $2.73 Million - $3.74 Million	21,496 New	21,496 $3.51 Million
Q1 2021 May 13, 2021	SELL	$126.83 - $175.69 $810,824 - $1.12 Million	-6,393 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$122.97 - $147.0 $786,147 - $939,771	6,393 New	6,393 $831,000
Q2 2020 Aug 07, 2020	SELL	$104.21 - $156.44 $1.72 Million - $2.58 Million	-16,471 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$93.12 - $133.99 $979,808 - $1.41 Million	10,522 Added 176.87%	16,471 $1.79 Million
Q4 2019 Feb 12, 2020	BUY	$74.51 - $124.23 $15,945 - $26,585	214 Added 3.73%	5,949 $685,000
Q3 2019 Nov 08, 2019	SELL	$70.9 - $87.82 $628,032 - $777,909	-8,858 Reduced 60.7%	5,735 $461,000
Q2 2019 Aug 09, 2019	BUY	$65.86 - $92.79 $297,226 - $418,761	4,513 Added 44.77%	14,593 $1.06 Million
Q1 2019 May 13, 2019	BUY	$72.76 - $93.45 $733,420 - $941,976	10,080 New	10,080 $942,000
Q1 2018 May 03, 2018	SELL	$115.92 - $148.54 $350,194 - $448,739	-3,021 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$114.49 - $139.98 $345,874 - $422,879	3,021	3,021 $384,000

Others Institutions Holding ALNY

# of Institutions

649

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.22M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $34.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Alnylam Pharmaceuticals, Inc. Transaction History